• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Bay g 2821对无水肿志愿者的利尿作用。

Diuretic action of Bay g 2821 in oedema-free volunteers.

作者信息

Loew D

出版信息

Curr Med Res Opin. 1977;4(7):455-61. doi: 10.1185/03007997709109333.

DOI:10.1185/03007997709109333
PMID:844325
Abstract

The sulphonamide-free diuretic Bay g 2821 was tested under standardized conditions 43 oedema-free volunteers. The threshold dose was 10 mg (0.14 mg/kg). The doseresponse curve was practically linear for doses up to 80 mg. The excretion of sodium and chloride was very high, and that of potassium, magnesium and calcium markedly lower. Itarenal haemodynamic investigations showed that the inulin clearance was unchanged, and the PAH clearance increased slightly. The tubular reabsorption of sodium and chloride was inhibited. Side-effects after a single oral dose did not occur.

摘要

在标准化条件下,对43名无水肿的志愿者测试了无磺胺类利尿剂Bay g 2821。阈剂量为10毫克(0.14毫克/千克)。剂量高达80毫克时,剂量-反应曲线实际上呈线性。钠和氯的排泄非常高,而钾、镁和钙的排泄明显较低。肾脏血流动力学研究表明,菊粉清除率未变,对氨基马尿酸清除率略有增加。钠和氯的肾小管重吸收受到抑制。单次口服给药后未出现副作用。

相似文献

1
Diuretic action of Bay g 2821 in oedema-free volunteers.Bay g 2821对无水肿志愿者的利尿作用。
Curr Med Res Opin. 1977;4(7):455-61. doi: 10.1185/03007997709109333.
2
An orally active adenosine A1 receptor antagonist, FK838, increases renal excretion and maintains glomerular filtration rate in furosemide-resistant rats.一种口服活性腺苷A1受体拮抗剂FK838可增加呋塞米抵抗大鼠的肾排泄并维持肾小球滤过率。
Br J Pharmacol. 2003 Aug;139(8):1383-8. doi: 10.1038/sj.bjp.0705370.
3
Activity of a new high efficiency diuretic in man: piretanide (HOE 118).一种新型高效利尿剂在人体中的活性:吡咯他尼(HOE 118)。
Br J Clin Pharmacol. 1980 Jun;9(6):577-83. doi: 10.1111/j.1365-2125.1980.tb01083.x.
4
The mechanism of action of Bay g 2821: a new diuretic.新型利尿剂Bay g 2821的作用机制
Curr Med Res Opin. 1977;4(7):462-8. doi: 10.1185/03007997709109334.
5
Effects of ozolinone, a diuretic active metabolite of etozoline, on renal function. I. Clearance studies in dogs.
Naunyn Schmiedebergs Arch Pharmacol. 1978 Oct;304(3):283-7. doi: 10.1007/BF00507970.
6
Renal actions of azosemide. 1. Clearance investigations in dogs.
Arzneimittelforschung. 1981;31(2):346-50.
7
Diuretic effects of Bay g 2821 in patients with advanced renal failure.
Curr Med Res Opin. 1977;4(8):574-9. doi: 10.1185/03007997709115272.
8
The diuretic action of 8-cyclopentyl-1,3-dipropylxanthine, a selective A1 adenosine receptor antagonist.8-环戊基-1,3-二丙基黄嘌呤(一种选择性A1腺苷受体拮抗剂)的利尿作用
Br J Pharmacol. 1993 May;109(1):271-7. doi: 10.1111/j.1476-5381.1993.tb13564.x.
9
Some effects of metolazone on electrolyte transport.美托拉宗对电解质转运的一些作用。
Ups J Med Sci. 1987;92(1):19-35. doi: 10.3109/03009738709178675.
10
Glomerular filtration rate and effective renal plasma flow following treatment with phenobarbital.
Arch Int Pharmacodyn Ther. 1976 Sep;223(1):107-13.

引用本文的文献

1
Comparison of the effects of muzolimine and furosemide in patients with end-stage renal failure on chronic dialysis.
Eur J Clin Pharmacol. 1981;20(1):23-6. doi: 10.1007/BF00554662.
2
Metabolic effects of long-term therapy with muzolimine and chlorthalidone in hypertension.
Eur J Clin Pharmacol. 1987;33(5):515-7. doi: 10.1007/BF00544246.
3
Comparison of the pharmacodynamic effect of muzolimine and furosemide in patients with advanced chronic renal insufficiency.晚期慢性肾功能不全患者中莫唑胺与呋塞米药效学作用的比较。
Eur J Clin Pharmacol. 1978 Dec 18;14(6):399-403. doi: 10.1007/BF00716380.
4
Pharmacokinetics of a single oral dose of muzolimine in cardiac failure.
Eur J Clin Pharmacol. 1979 Mar 26;15(2):105-8. doi: 10.1007/BF00609872.